News
UK’s governing body, NICE, has decided to stop its recommendation of asthma drug, Xolair, following inconsistencies in clinical trial data. Britain’s National Institute for Health and Clinical Excellence (NICE) has decided to withdraw its recommendation for…
GSK and XenoPort mutually agree to end their collaboration on restless leg syndrome drug, Horizant. GSK and XenoPort have announced mutual termination of their collaboration concerning restless leg…
Novartis is confident its current pipeline will secure further growth for the company over the next five years. Swiss pharmaceutical company, Novartis, has given a positive assessment of the battle it is facing to produce…
What will Obama’s re-election as US President mean for the healthcare reform? Barack Obama’s vision to overhaul the US healthcare system was opposed by many, but his victory last night in…
Rheumatoid arthritis treatment, Xeljanz, by Pfizer has been approved for use in the United States. Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the…
Ahead of an advisory committee meeting, the FDA has released a review of Novo Nordisk’s insulin, Tresiba, questioning its safety risks. US regulators believe that Novo Nordisk’s new long-acting, once-a-day insulin, Tresiba, has a notable, but…
Phase 2 clinical trials of Amgen’s experimental drug AMG145 show a significant improvement in cholesterol reduction. Amgen has announced that its experimental drug AMG145 reduced levels of “bad” cholesterol by up to…
Positive phase 3 clinical trial data of BioMarin’s experimental Morquio A Syndrome drug, GALNS, send the company’s shares up 30%. BioMarin Pharmaceuticals has announced that the phase 3 clinical trials of the company’s experimental drug, GALNS, met…
Efpia has asked the Greek government to promise not to get in further debt in exchange for capping the price of the country’s medicines bill. International drug makers have offered to cap the total amount the Greek government has to pay for its…
